A. Kornbluth

A. Kornbluth, C. Siegel, C. Ha, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

A. Kornbluth, S. Lichtiger, J. George, 2006, The American Journal of Gastroenterology.

Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.

A. Kornbluth, D. Present, T. Ullman, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Endoscopic management of intestinal strictures in Crohn's disease: Commentary

A. Kornbluth, 2007 .

Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.

D. Ahnen, A. Kornbluth, D. Sachar, 1995, Gastroenterology.

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel

G. Kaplan, D. Rubin, L. Baidoo, 2016, Inflammatory bowel diseases.

Ischemic Disease of the Small and Large Bowel

A. Kornbluth, A. Grinspan, 2014 .

P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy

P. Rutgeerts, G. D'Haens, A. Kornbluth, 2008 .

A. Kornbluth, C. Ha, 2018 .

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

A. Kornbluth, C. Siegel, B. Christensen, 2020, Journal of Crohn's & colitis.

Abstracts of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation

J. Makanyanga, A. Kornbluth, R. Mountifield, 2021 .

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

P. Rutgeerts, P. Rutgeerts, A. Kornbluth, 2015, Alimentary pharmacology & therapeutics.

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

J. Lewis, A. Kornbluth, D. Katzka, 2002, American Journal of Gastroenterology.

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

A. Kornbluth, 2020, Inflammatory bowel diseases.

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

P. Rutgeerts, A. Kornbluth, L. Peyrin-Biroulet, 2013, Gut.

Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease

A. Kornbluth, D. Present, S. Lichtiger, 2008, The American Journal of Gastroenterology.

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

N. Harpaz, S. Hossain, C. Bodian, 2007, Gastroenterology.

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

A. Kornbluth, D. Present, S. Kane, 2008, The American Journal of Gastroenterology.

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.

N. Harpaz, S. Hossain, C. Bodian, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial.

A. Kornbluth, H. Janowitz, P. Salomon, 1990, Journal of clinical gastroenterology.

Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial.

A. Kornbluth, H. Janowitz, P. Salomon, 1990, Journal of clinical gastroenterology.

Newer therapies for inflammatory bowel disease

A. Kornbluth, P. Legnani, 2004, Current treatment options in gastroenterology.

Positioning Therapy for Ulcerative Colitis

A. Kornbluth, A. Grinspan, 2015, Current Gastroenterology Reports.

W1105 Cyclosporine and Infliximab As Delayed Salvage Therapy for Each Other in Patients with Steroid-Refractory Ulcerative Colitis

A. Kornbluth, D. Present, T. Ullman, 2009 .

Factors associated with short- and long-term outcomes of therapy for Crohn's disease.

P. Rutgeerts, A. Kornbluth, W. Sandborn, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

A. Kornbluth, C. Ha, Jagrati Mathur, 2015, Expert review of gastroenterology & hepatology.

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

D. Rubin, S. Hanauer, B. Sands, 2010, Inflammatory bowel diseases.

How Effective Are Current Drugs For Crohn's Disease?: A Meta‐Analysis

A. Kornbluth, J. Aisenberg, H. Janowitz, 1992, Journal of clinical gastroenterology.

Cyclosporine in inflammatory bowel disease

A. Kornbluth, 1999, Current gastroenterology reports.

Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing: A Post hoc Analysis from SONIC

P. Rutgeerts, G. D'Haens, A. Kornbluth, 2015, Inflammatory bowel diseases.

Optimizing drug therapy in inflammatory bowel disease

A. Kornbluth, A. Swaminath, 2007, Current gastroenterology reports.

Immunomodulator therapy in inflammatory bowel disease

A. Kornbluth, P. Legnani, 2001, Current treatment options in gastroenterology.

Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature

A. Kornbluth, D. Present, A. Shah, 2005, Alimentary pharmacology & therapeutics.

Complete bowel obstruction following initial response to infliximab therapy for crohn's disease: A series of a newly described complication

A. Kornbluth, D. Present, E. Scherl, 2000 .

Therapeutic options in the management of strictures in Crohn's disease.

A. Kornbluth, P. Legnani, 2002, Gastrointestinal endoscopy clinics of North America.

Cyclosporin for severe ulcerative colitis: a user's guide.

S. Hanauer, A. Kornbluth, D. Present, 1997, The American journal of gastroenterology.

Infliximab, azathioprine, or combination therapy for Crohn's disease.

P. Rutgeerts, G. D'Haens, A. Kornbluth, 2010, The New England journal of medicine.

Ulcerative colitis practice guidelines in adults

A. Kornbluth, D. Sachar, 1997 .

Response to Dr. Spada and Colleagues

B. Lewis, A. Kornbluth, A. Cheifetz, 2007, The American Journal of Gastroenterology.

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Alphonso Brown, B. Lewis, A. Kornbluth, 2006, The American Journal of Gastroenterology.

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

A. Kornbluth, D. Sachar, 2004, American Journal of Gastroenterology.

The Effect of Intravenous Cyclosporine on Rates of Colonic Surgery in Hospitalized Patients With Severe Crohn’s Colitis

A. Kornbluth, D. Present, M. Lazarev, 2012, Journal of clinical gastroenterology.

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis.

A. Kornbluth, 2011, Gastroenterology & hepatology.

Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Pro argument.

A. Kornbluth, 2003, Inflammatory bowel diseases.

Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.

Eun Soo Kim, M. Dubinsky, A. Kornbluth, 2020, Gastroenterology.

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

J. Clemente, J. Faith, I. Mogno, 2019, Gut.

Established Crohn’s Disease

A. Kornbluth, P. Legnani, W. Voderholzer, 2014 .

Response to Dr. Levenstein's Letter

A. Kornbluth, J. Jackson, 2008, The American Journal of Gastroenterology.

The fate of indefinite dysplasia in ulcerative colitis

N. Harpaz, A. Kornbluth, S. Itzkowitz, 2003 .

Is cyclosporine as effective in chronic ul cerative colitis as in severe ulcerative colitis

A. Kornbluth, D. Present, H. Janowitz, 1998 .

Serologic and genetic markers do not aid in the determination of the clinical course and severity of patients with inflammatory bowel disease.

A. Kornbluth, S. Murphy, 2008, Inflammatory bowel diseases.

Controversies in mucosal healing in ulcerative colitis.

P. Higgins, A. Kornbluth, S. Kane, 2009, Inflammatory bowel diseases.

Treatment responses in collagenous colitis

N. Harpaz, A. Kornbluth, D. Sachar, 2001, American Journal of Gastroenterology.

Double balloon enteroscopy in Crohn's disease: Where are we now and where should we go?

A. Kornbluth, S. Murphy, 2011, Inflammatory bowel diseases.

Clinical Presentation and Outcomes of Inflammatory Bowel Disease Patients Admitted to the Intensive Care Unit

A. Kornbluth, C. Ha, E. Maser, 2013, Journal of clinical gastroenterology.

Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?

A. Kornbluth, C. Ha, 2010, Current gastroenterology reports.

Do Black and Hispanic Americans With Inflammatory Bowel Disease (IBD) Receive Inferior Care Compared With White Americans? Uneasy Questions and Speculations

A. Kornbluth, J. Jackson, 2007, The American Journal of Gastroenterology.

Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis.

A. Kornbluth, C. Ha, 2014, Gastroenterology & hepatology.

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

C. Bernstein, A. Kornbluth, 2017, The American Journal of Gastroenterology.

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

A. Kornbluth, J. George, P. Legnani, 2020, Inflammatory bowel diseases.

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

A. Kornbluth, M. Kappelman, M. Agrawal, 2022, Inflammatory bowel diseases.

Difficult differential diagnoses in IBD: ileitis and indeterminate colitis.

A. Kornbluth, P. Legnani, 2001, Seminars in gastrointestinal disease.

Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.

H. Sacks, A. Kornbluth, H. Janowitz, 1993, Journal of clinical gastroenterology.

Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux.

A. Kornbluth, A. Swaminath, P. Legnani, 2004, Inflammatory bowel diseases.

Video capsule endoscopy in inflammatory bowel disease: past, present, and future.

B. Lewis, A. Kornbluth, Blair S Lewis, 2004, Inflammatory bowel diseases.

Evolution of Endoscopic Activity Scores in Patients With Crohn's Disease Under Azathioprine and/or Infliximab: A Post-Hoc Analysis of the Sonic Data

P. Rutgeerts, G. D'Haens, M. Ferrante, 2011 .

ICCE consensus for inflammatory bowel disease.

J. A. Leighton, J. Leighton, A. Kornbluth, 2005, Endoscopy.

Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management

Jeffrey Brooks, C. Gostout, A. Kornbluth, 2011, Obesity surgery.

M1507: A Novel Adjustable Intragastric Balloon (IGB) to Treat Obesity: A Pilot Study

C. Gostout, A. Kornbluth, S. Peikin, 2010 .

What happened to drug trials in ulcerative colitis? problems, PPARs, placebos, and (possible) progress

A. Kornbluth, 2001, American Journal of Gastroenterology.

Association of Steroid-Free Clinical Remission and Complete Mucosal Healing at 6 Months With Clinical Outcome at 1 Year: A Post-Hoc Analysis of SONIC trial Data

P. Rutgeerts, G. D'Haens, A. Kornbluth, 2011 .

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

N. Harpaz, A. Kornbluth, D. Present, 2007, Diseases of the colon and rectum.

Double balloon enteroscopy in Crohn's disease: background and current state of play.

A. Kornbluth, S. Murphy, 2012, Current drug targets.

Small bowel tumours: yield of enteroscopy.

J. Waye, B. Lewis, A. Kornbluth, 1991, Gut.

Does hormonal therapy have any benefit for bleeding angiodysplasia?

J. Waye, B. Lewis, A. Kornbluth, 1992, Journal of clinical gastroenterology.

Immunosuppressive drugs in Crohn's disease.

A. Kornbluth, J. George, Sachar Db, 1994, The Gastroenterologist.

791 Adjustable Intragastric Balloons: A 12 Month Pilot Trial in Endoscopic Weight Loss Management

C. Gostout, A. Kornbluth, S. Peikin, 2011 .

Diagnosing Crohn's disease: an economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures.

L. Pizzi, N. Goldfarb, V. Sikirica, 2004, Disease management : DM.

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

A. Kornbluth, A. Trindade, T. Ullman, 2011, Inflammatory bowel diseases.

Small bowel tumours: yield of enteroscopy.

J. Waye, B. Lewis, A. Kornbluth, 1991, Gut.

IS CAPSULE ENDOSCOPY EMERGING AS A NECESSARY AND EFFECTIVE TOOL IN THE DIAGNOSTIC EVALUATION OF PATIENTS WITH SUSPECTED OR KNOWN CROHN??S DISEASE?

A. Kornbluth, P. Legnani, 2006 .

Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux.

A. Kornbluth, A. Swaminath, P. Legnani, 2004, Inflammatory bowel diseases.

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

P. Rutgeerts, A. Kornbluth, L. Peyrin-Biroulet, 2013, Gut.

Video capsule endoscopy in inflammatory bowel disease: past, present, and future.

B. Lewis, A. Kornbluth, P. Legnani, 2004, Inflammatory bowel diseases.

What happened to drug trials in ulcerative colitis? Problems, PPARs, placebos, and (possible) progress.

A. Kornbluth, 2001 .

Sonic: a Randomized, Double-Blind, Controlled Trial Comparing Infliximab and Infliximab Plus Azathioprine to Azathioprine in Patients with Crohnʼs Disease Naive to Immunomodulators and Biologic Therapy

A. Kornbluth, W. Sandborn, J. Colombel, 2008 .